Literature DB >> 11751614

PRL signal transduction in the epithelial compartment of rat prostate maintained as long-term organ cultures in vitro.

Tommi J Ahonen1, Pirkko L Härkönen, Hallgeir Rui, Marja T Nevalainen.   

Abstract

Using long-term organ cultures of rat prostate tissue explants, we previously demonstrated that PRL both stimulates proliferation and acts as an androgen-independent suppressor of apoptosis in prostate epithelial cells, leading to epithelial hyperplasia. In this work we delineate intracellular signaling molecules activated by PRL in prostate tissue to identify candidate signaling proteins that are responsible for maintaining survival and proliferation of prostate epithelium in androgen-deprived growth environment. We now show that signal transducer and activator of transcription-5a (Stat5a) and Stat5b become tyrosine phosphorylated in response to PRL stimulation in rat prostate using prostate organ culture as an experimental model. Stat5 was translocated to the nuclei of epithelial cells of prostate tissue as demonstrated by immunohistochemistry. Furthermore, EMSA showed PRL-inducible binding of Stat5a homodimers and Stat5a/5b heterodimers to the PRL response element of the beta-casein gene promoter. Signaling molecules Stat3, Stat1, MAPK, or protein kinase B, which can be activated by PRL in other target cells, were not activated by PRL in prostate tissue. Furthermore, we show that Stat5a and Stat5b are continuously phosphorylated in rat prostate in vivo, although they are expressed to varying degree in separate lobes of rat prostate. Collectively, our results suggest that PRL signaling in rat prostate tissue is primarily transduced via Stat5a and Stat5b. The Stat5 pathway represents one candidate signaling mechanism, used by PRL and possibly other growth factors and cytokines, that supports the viability of prostate epithelial cells during long-term androgen deprivation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11751614     DOI: 10.1210/endo.143.1.8576

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  20 in total

Review 1.  Minireview: prolactin regulation of adult stem cells.

Authors:  Lucila Sackmann-Sala; Jacques-Emmanuel Guidotti; Vincent Goffin
Journal:  Mol Endocrinol       Date:  2015-03-20

2.  Effects of metoclopramide on mRNA levels of steroid 5α-reductase isozymes in prostate of adult rats.

Authors:  Pilar Sánchez; Jesús M Torres; Beatriz Castro; José F Frías; Esperanza Ortega
Journal:  J Physiol Biochem       Date:  2012-07-18       Impact factor: 4.158

3.  Nuclear Stat5a/b predicts early recurrence and prostate cancer-specific death in patients treated by radical prostatectomy.

Authors:  Tuomas Mirtti; Benjamin E Leiby; Junaid Abdulghani; Elina Aaltonen; Miia Pavela; Anita Mamtani; Kalle Alanen; Lars Egevad; Torvald Granfors; Andreas Josefsson; Par Stattin; Anders Bergh; Marja T Nevalainen
Journal:  Hum Pathol       Date:  2012-09-29       Impact factor: 3.466

Review 4.  Signal transducer and activator of transcription 5a/b: biomarker and therapeutic target in prostate and breast cancer.

Authors:  Mateusz Koptyra; Shilpa Gupta; Pooja Talati; Marja T Nevalainen
Journal:  Int J Biochem Cell Biol       Date:  2011-06-17       Impact factor: 5.085

5.  Stat5 promotes metastatic behavior of human prostate cancer cells in vitro and in vivo.

Authors:  Lei Gu; Paraskevi Vogiatzi; Martin Puhr; Ayush Dagvadorj; Jacqueline Lutz; Amy Ryder; Sankar Addya; Paolo Fortina; Carlton Cooper; Benjamin Leiby; Abhijit Dasgupta; Terry Hyslop; Lukas Bubendorf; Kalle Alanen; Tuomas Mirtti; Marja T Nevalainen
Journal:  Endocr Relat Cancer       Date:  2010-05-18       Impact factor: 5.678

6.  Inhibition of Stat5a/b Enhances Proteasomal Degradation of Androgen Receptor Liganded by Antiandrogens in Prostate Cancer.

Authors:  David T Hoang; Lei Gu; Zhiyong Liao; Feng Shen; Pooja G Talati; Mateusz Koptyra; Shyh-Han Tan; Elyse Ellsworth; Shilpa Gupta; Heather Montie; Ayush Dagvadorj; Saija Savolainen; Benjamin Leiby; Tuomas Mirtti; Diane E Merry; Marja T Nevalainen
Journal:  Mol Cancer Ther       Date:  2014-12-31       Impact factor: 6.261

7.  N-terminal truncation of Stat5a/b circumvents PIAS3-mediated transcriptional inhibition of Stat5 in prostate cancer cells.

Authors:  Ayush Dagvadorj; Shyh-Han Tan; Zhiyong Liao; Jianwu Xie; Martti Nurmi; Kalle Alanen; Hallgeir Rui; Tuomas Mirtti; Marja T Nevalainen
Journal:  Int J Biochem Cell Biol       Date:  2010-09-18       Impact factor: 5.085

8.  Jak2-Stat5a/b Signaling Induces Epithelial-to-Mesenchymal Transition and Stem-Like Cell Properties in Prostate Cancer.

Authors:  Pooja G Talati; Lei Gu; Elyse M Ellsworth; Melanie A Girondo; Marco Trerotola; David T Hoang; Benjamin Leiby; Ayush Dagvadorj; Peter A McCue; Costas D Lallas; Edouard J Trabulsi; Leonard Gomella; Andrew E Aplin; Lucia Languino; Alessandro Fatatis; Hallgeir Rui; Marja T Nevalainen
Journal:  Am J Pathol       Date:  2015-09       Impact factor: 4.307

Review 9.  Signal transducer and activator of transcription 5A/B in prostate and breast cancers.

Authors:  Shyh-Han Tan; Marja T Nevalainen
Journal:  Endocr Relat Cancer       Date:  2008-06       Impact factor: 5.678

10.  Targeting stromal androgen receptor suppresses prolactin-driven benign prostatic hyperplasia (BPH).

Authors:  Kuo-Pao Lai; Chiung-Kuei Huang; Lei-Ya Fang; Kouji Izumi; Chi-Wen Lo; Ronald Wood; Jon Kindblom; Shuyuan Yeh; Chawnshang Chang
Journal:  Mol Endocrinol       Date:  2013-07-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.